Clinical Trials Browser

Has results × Carcinoma × dacomitinib × Clear all

NCT00818441 2019-01-08

Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

Phase 2 Completed

119 enrolled 12 charts

Carcinoma